Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-18

Clinical Trial Update: High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating high-dose amoxicillin and metronidazole plus bismuth for Helicobacter pylori infection (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Bismuth (bismuth)
  • METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED